|
|
Article: New Arthritis Drug Sells Briskly; Insurers Fear A Crippled Bottom Line.
- Article from:
- Knight Ridder/Tribune Business News
- Article date:
- May 24, 1999
- Author:
CopyrightCOPYRIGHT 1999 Knight-Ridder/Tribune Business News. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Knight Ridder/Tribune Business News
May 23 -- Emma Moreno was in constant pain.
Getting out of bed, climbing stairs, rising up from her chair were all things she dreaded because of the agony they would cause. At times, the 42-year-old computer programmer, who suffers from arthritis, resorted to using a cane to walk.
But in January, her doctor prescribed Celebrex, a new anti-inflammatory drug. "It brought me back to life. Simple as that," said Moreno, who lives in Lynn.
For Moreno, Celebrex is a savior. But for insurance companies, it's a potential nightmare. At nearly $3 a day, it represents a crippling budget buster. By contrast, ...